ProQR Therapeutics N.V (NASDAQ: PRQR) is 32.12% higher on its value in year-to-date trading and has touched a low of $1.07 and a high of $4.62 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PRQR stock was last observed hovering at around $2.13 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $2.18, the stock is 10.94% and 22.49% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.18 million and changing 2.35% at the moment leaves the stock -4.73% off its SMA200. PRQR registered -17.74% loss for a year compared to 6-month loss of -17.74%. The firm has a 50-day simple moving average (SMA 50) of $1.7798 and a 200-day simple moving average (SMA200) of $2.28825.
The stock witnessed a 22.47% gain in the last 1 month and extending the period to 3 months gives it a 59.12%, and is 0.93% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.12% over the week and 6.40% over the month.
Profit margin for the company is -158.84%. Distance from 52-week low is 103.74% and -52.81% from its 52-week high. The company has generated returns on investments over the last 12 months (-33.39%).
The EPS is expected to shrink by -14.27% this year
74.0 institutions hold shares in ProQR Therapeutics N.V (PRQR), with institutional investors hold 62.18% of the company’s shares. The shares outstanding are 105.34M, and float is at 72.22M with Short Float at 0.89%. Institutions hold 50.95% of the Float.
The top institutional shareholder in the company is PRIVIUM FUND MANAGEMENT B.V. with over 5.58 million shares valued at $9.21 million. The investor’s holdings represent 6.8336 of the PRQR Shares outstanding. As of 2024-06-30, the second largest holder is ADAGE CAPITAL PARTNERS GP, L.L.C. with 3.63 million shares valued at $6.02 million to account for 4.4394 of the shares outstanding. The other top investors are ECOR1 CAPITAL, LLC which holds 2.04 million shares representing 2.5014 and valued at over $3.39 million, while M28 CAPITAL MANAGEMENT LP holds 1.2484 of the shares totaling 1.02 million with a market value of $1.69 million.
